Which has higher valuation & earnings, RDNT or GH?

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.19 -$18.65M -$0.18 N/A Guardant Health $982.02M 17.77 -$416.28M -$3.39 N/A

Does the media favor RDNT or GH?

In the previous week, Guardant Health had 5 more articles in the media than RadNet. MarketBeat recorded 12 mentions for Guardant Health and 7 mentions for RadNet. RadNet's average media sentiment score of 0.72 beat Guardant Health's score of 0.52 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RDNT or FMS?

In the previous week, RadNet had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 7 mentions for RadNet and 2 mentions for Fresenius Medical Care AG & Co. KGaA. RadNet's average media sentiment score of 0.72 beat Fresenius Medical Care AG & Co. KGaA's score of 0.61 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RDNT or BTSG?

In the previous week, BrightSpring Health Services had 9 more articles in the media than RadNet. MarketBeat recorded 16 mentions for BrightSpring Health Services and 7 mentions for RadNet. BrightSpring Health Services' average media sentiment score of 1.14 beat RadNet's score of 0.72 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 8 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, HIMS or RDNT?

Hims & Hers Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 2.65 $128.37M -$0.09 N/A RadNet $2.04B 2.19 -$18.65M -$0.18 N/A

Does the media refer more to HIMS or RDNT?

In the previous week, Hims & Hers Health had 13 more articles in the media than RadNet. MarketBeat recorded 20 mentions for Hims & Hers Health and 7 mentions for RadNet. RadNet's average media sentiment score of 0.72 beat Hims & Hers Health's score of 0.66 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 8 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, PACS or RDNT?

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.09 $191.54M $1.56 23.33 RadNet $2.04B 2.19 -$18.65M -$0.18 N/A

Is PACS or RDNT more profitable?

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% RadNet -0.66% 2.77% 0.97%

Does the media prefer PACS or RDNT?

In the previous week, RadNet had 5 more articles in the media than PACS Group. MarketBeat recorded 7 mentions for RadNet and 2 mentions for PACS Group. RadNet's average media sentiment score of 0.72 beat PACS Group's score of 0.43 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

RadNet (RDNT) Competitors

$56.71 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$56.88 +0.16 (+0.29%)

As of 06/12/2026 05:24 PM Eastern

Compare

RDNT vs. GH, FMS, BTSG, HIMS, and PACS

Should you buy RadNet stock or one of its competitors? MarketBeat compares RadNet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RadNet include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does RadNet compare to Guardant Health?

RadNet (NASDAQ:RDNT) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

RadNet has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market.

RadNet currently has a consensus price target of $87.43, indicating a potential upside of 54.17%. Guardant Health has a consensus price target of $141.95, indicating a potential upside of 7.85%. Given RadNet's higher possible upside, analysts clearly believe RadNet is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96

77.9% of RadNet shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Guardant Health had 5 more articles in the media than RadNet. MarketBeat recorded 12 mentions for Guardant Health and 7 mentions for RadNet. RadNet's average media sentiment score of 0.72 beat Guardant Health's score of 0.52 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.19	-$18.65M	-$0.18	N/A
Guardant Health	$982.02M	17.77	-$416.28M	-$3.39	N/A

RadNet has a net margin of -0.66% compared to Guardant Health's net margin of -40.10%. RadNet's return on equity of 2.77% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Guardant Health	-40.10%	N/A	-26.42%

Summary

RadNet beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

RadNet (NASDAQ:RDNT) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

In the previous week, RadNet had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 7 mentions for RadNet and 2 mentions for Fresenius Medical Care AG & Co. KGaA. RadNet's average media sentiment score of 0.72 beat Fresenius Medical Care AG & Co. KGaA's score of 0.61 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.19	-$18.65M	-$0.18	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.56	$1.11B	$1.90	12.12

RadNet presently has a consensus target price of $87.43, indicating a potential upside of 54.17%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 21.56%. Given RadNet's stronger consensus rating and higher probable upside, equities analysts plainly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to RadNet's net margin of -0.66%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

RadNet beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does RadNet compare to BrightSpring Health Services?

RadNet (NASDAQ:RDNT) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

BrightSpring Health Services has a net margin of 2.27% compared to RadNet's net margin of -0.66%. BrightSpring Health Services' return on equity of 14.63% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
BrightSpring Health Services	2.27%	14.63%	4.41%

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

RadNet currently has a consensus price target of $87.43, indicating a potential upside of 54.17%. BrightSpring Health Services has a consensus price target of $58.53, indicating a potential downside of 7.43%. Given RadNet's higher probable upside, equities research analysts clearly believe RadNet is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

In the previous week, BrightSpring Health Services had 9 more articles in the media than RadNet. MarketBeat recorded 16 mentions for BrightSpring Health Services and 7 mentions for RadNet. BrightSpring Health Services' average media sentiment score of 1.14 beat RadNet's score of 0.72 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	8 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.19	-$18.65M	-$0.18	N/A
BrightSpring Health Services	$13.65B	0.91	$190.67M	$1.41	44.84

Summary

BrightSpring Health Services beats RadNet on 12 of the 16 factors compared between the two stocks.

How does RadNet compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

In the previous week, Hims & Hers Health had 13 more articles in the media than RadNet. MarketBeat recorded 20 mentions for Hims & Hers Health and 7 mentions for RadNet. RadNet's average media sentiment score of 0.72 beat Hims & Hers Health's score of 0.66 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	8 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of RadNet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hims & Hers Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.65	$128.37M	-$0.09	N/A
RadNet	$2.04B	2.19	-$18.65M	-$0.18	N/A

Hims & Hers Health has a net margin of -0.56% compared to RadNet's net margin of -0.66%. Hims & Hers Health's return on equity of 6.10% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
RadNet	-0.66%	2.77%	0.97%

Hims & Hers Health currently has a consensus target price of $28.70, indicating a potential upside of 6.89%. RadNet has a consensus target price of $87.43, indicating a potential upside of 54.17%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	3 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.06
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Summary

Hims & Hers Health beats RadNet on 11 of the 17 factors compared between the two stocks.

How does RadNet compare to PACS Group?

PACS Group (NYSE:PACS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
RadNet	-0.66%	2.77%	0.97%

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.09	$191.54M	$1.56	23.33
RadNet	$2.04B	2.19	-$18.65M	-$0.18	N/A

77.9% of RadNet shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, RadNet had 5 more articles in the media than PACS Group. MarketBeat recorded 7 mentions for RadNet and 2 mentions for PACS Group. RadNet's average media sentiment score of 0.72 beat PACS Group's score of 0.43 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group currently has a consensus price target of $48.00, indicating a potential upside of 31.89%. RadNet has a consensus price target of $87.43, indicating a potential upside of 54.17%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Summary

PACS Group and RadNet tied by winning 8 of the 16 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.46B	$5.70B	$6.53B	$12.05B
Dividend Yield	N/A	1.54%	2.67%	5.67%
P/E Ratio	-315.04	35.06	24.22	24.42
Price / Sales	2.19	22.17	511.60	109.90
Price / Cash	17.59	16.60	27.48	37.92
Price / Book	3.23	3.12	10.65	6.82
Net Income	-$18.65M	$218.81M	$3.57B	$337.56M
7 Day Performance	4.71%	3.25%	0.58%	1.17%
1 Month Performance	8.25%	1.31%	1.54%	3.16%
1 Year Performance	2.35%	14.98%	25.40%	30.58%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	3.261 of 5 stars	$56.71 flat	$87.43 +54.2%	+2.3%	$4.46B	$2.04B	N/A	11,264	Gap Up
GH Guardant Health	2.0641 of 5 stars	$124.89 -0.6%	$139.80 +11.9%	+167.0%	$16.66B	$982.02M	N/A	2,506
FMS Fresenius Medical Care AG & Co. KGaA	4.2755 of 5 stars	$21.79 -1.1%	$28.00 +28.5%	-19.5%	$11.90B	$22.20B	11.47	1,488	Short Interest Increase
BTSG BrightSpring Health Services	4.2209 of 5 stars	$59.22 +3.2%	$58.53 -1.2%	+198.5%	$11.32B	$13.65B	42.00	23,500	Positive News
HIMS Hims & Hers Health	3.2953 of 5 stars	$27.08 +3.4%	$28.70 +6.0%	-51.5%	$6.06B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, HIMS, and PACS

How does RadNet compare to Guardant Health?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to Hims & Hers Health?

Summary

How does RadNet compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, HIMS, and PACS

How does RadNet compare to Guardant Health?

Which has more volatility and risk, RDNT or GH?

Do analysts recommend RDNT or GH?

Do insiders & institutionals believe in RDNT or GH?

Does the media favor RDNT or GH?

Which has higher valuation & earnings, RDNT or GH?

Is RDNT or GH more profitable?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Does the media favor RDNT or FMS?

Which has more risk & volatility, RDNT or FMS?

Which has stronger earnings and valuation, RDNT or FMS?

Do analysts recommend RDNT or FMS?

Is RDNT or FMS more profitable?

Do insiders and institutionals believe in RDNT or FMS?

Summary

How does RadNet compare to BrightSpring Health Services?

Is RDNT or BTSG more profitable?

Which has more risk and volatility, RDNT or BTSG?

Do analysts recommend RDNT or BTSG?

Does the media favor RDNT or BTSG?

Do insiders & institutionals believe in RDNT or BTSG?

Which has better valuation and earnings, RDNT or BTSG?

Summary

How does RadNet compare to Hims & Hers Health?

Which has more volatility & risk, HIMS or RDNT?

Does the media refer more to HIMS or RDNT?

Do institutionals and insiders have more ownership in HIMS or RDNT?

Which has preferable valuation and earnings, HIMS or RDNT?

Is HIMS or RDNT more profitable?

Do analysts rate HIMS or RDNT?

Summary

How does RadNet compare to PACS Group?

Is PACS or RDNT more profitable?

Which has better earnings and valuation, PACS or RDNT?

Do insiders and institutionals have more ownership in PACS or RDNT?

Does the media prefer PACS or RDNT?

Do analysts recommend PACS or RDNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools